Nektar Therapeutics (NKTR)

• Market cap: $1.34B
• 1 day: 8.85%
• 5 days: 7.71%
• 1 month: 4.99%
• 3 months: 128.25%
• 6 months: 549.11%
• Year to date: 355.55%
• 1 year: 309.28%
• 5 years: -73.92%
• 10 years: -71.21%
• Sector: Healthcare
• Industry: Biotechnology

About: Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.

Employees: 61